Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure-Reference-Cited by-同舟云学术

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure

Published:2018-01-12 Issue:5 Volume:58 Page:628-639
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Okour Malek¹^ORCID,Jacobson Pamala A.²,Ahmed Mariam A.²,Israni Ajay K.³,Brundage Richard C.²^ORCID

Affiliation:

1. Clinical Pharmacology Modeling and Simulation (CPMS) GlaxoSmithKline King of Prussia PA USA

2. Department of Experimental and Clinical Pharmacology College of Pharmacy University of Minnesota Minneapolis MN USA

3. Department of Medicine Department of Epidemiology and Community Health Hennepin County Medical Center and University of Minnesota Minneapolis MN USA

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1064

Reference56 articles.

1. OPTN/SRTR 2013 Annual Data Report: Kidney

2. The Evolution of Population Pharmacokinetic Models to Describe the Enterohepatic Recycling of Mycophenolic Acid in Solid Organ Transplantation and Autoimmune Disease

3. Clinical Pharmacokinetics of Mycophenolate Mofetil

4. Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics;Nowak I;Clin Chem,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap;Advanced Drug Delivery Reviews;2024-10

2. Limited Sampling Strategies Fail to Accurately Predict Mycophenolic Acid Area Under the Curve in Kidney Transplant Recipients and the Impact of Enterohepatic Recirculation;Therapeutic Drug Monitoring;2024-07-23

3. A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate;Molecular Pharmaceutics;2024-07-03

4. Consequences of differences in bio-analytical assays for the precision monitoring of immunosuppressive drugs;Therapeutic Drug Monitoring;2024

5. Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients;Xenobiotica;2023-11-02